×
Entrez Id:
43
Gene Symbol:
ACHE
ACHE
0.300
Therapeutic
phenotype
CTD_human
HI-6 assisted catalytic scavenging of VX by acetylcholinesterase choline binding site mutants.
27083141
2016
×
Entrez Id:
538
Gene Symbol:
ATP7A
ATP7A
0.300
Biomarker
phenotype
CTD_human
Prenatal treatment of mosaic mice (Atp7a mo-ms) mouse model for Menkes disease, with copper combined by dimethyldithiocarbamate (DMDTC).
22815746
2012
×
Entrez Id:
6334
Gene Symbol:
SCN8A
SCN8A
0.300
Biomarker
phenotype
CTD_human
The ataxia3 mutation in the N-terminal cytoplasmic domain of sodium channel Na(v)1.6 disrupts intracellular trafficking.
19261867
2009
×
Entrez Id:
135
Gene Symbol:
ADORA2A
ADORA2A
0.300
Biomarker
phenotype
CTD_human
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease.
16780890
2006
×
Entrez Id:
1565
Gene Symbol:
CYP2D6
CYP2D6
0.300
Biomarker
phenotype
CTD_human
Severe adverse effects in a newborn with two defective CYP2D6 alleles after exposure to paroxetine during late pregnancy.
15570195
2004
×
Entrez Id:
3350
Gene Symbol:
HTR1A
HTR1A
0.300
Biomarker
phenotype
CTD_human
Involvement of 5-hydroxytryptamine(1A) receptors in nicotine-induced tail tremor in rats.
11070179
2000
×
Entrez Id:
1132
Gene Symbol:
CHRM4
CHRM4
0.300
Biomarker
phenotype
CTD_human
Characterization of the muscarinic receptor subtype mediating pilocarpine-induced tremulous jaw movements in rats.
9920179
1999
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Therapeutic
phenotype
CTD_human
Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats.
9151294
1997
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Biomarker
phenotype
CTD_human
Role of central nicotinic and beta-adrenergic receptors in the onset and further development of tail-tremor induced by repeated nicotine administration to rats.
9151294
1997
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Biomarker
phenotype
CTD_human
Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats.
7902979
1993
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Therapeutic
phenotype
CTD_human
Effect of beta-adrenergic receptor antagonists on nicotine-induced tail-tremor in rats.
7902979
1993
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Biomarker
phenotype
CTD_human
Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.
8102213
1993
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Therapeutic
phenotype
CTD_human
Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.
8102213
1993
×
Entrez Id:
7200
Gene Symbol:
TRH
TRH
0.300
Therapeutic
phenotype
CTD_human
A study of the changes in motor behaviour caused by TRH on intracerebral injection.
103733
1979
×
Entrez Id:
7200
Gene Symbol:
TRH
TRH
0.300
Biomarker
phenotype
CTD_human
A study of the changes in motor behaviour caused by TRH on intracerebral injection.
103733
1979
×
Entrez Id:
7200
Gene Symbol:
TRH
TRH
0.300
Biomarker
phenotype
CTD_human
Studies on the neuropharmacology of thyrotropin releasing hormone (TRH) and a new TRH analog.
416961
1978
×
Entrez Id:
7200
Gene Symbol:
TRH
TRH
0.300
Therapeutic
phenotype
CTD_human
Studies on the neuropharmacology of thyrotropin releasing hormone (TRH) and a new TRH analog.
416961
1978
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Therapeutic
phenotype
CTD_human
Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors.
190674
1977
×
Entrez Id:
154
Gene Symbol:
ADRB2
ADRB2
0.300
Biomarker
phenotype
CTD_human
Tremor caused by sympathomimetics is mediated by beta2-adrenoreceptors.
190674
1977
×
Entrez Id:
6622
Gene Symbol:
SNCA
SNCA
0.110
Biomarker
phenotype
BEFREE
PD patients may manifest symptoms of postural instability, bradykinesia, and resting tremors as a result of increasing α-synuclein aggregation and neuron death with disease progression.
31601400
2019
×
Entrez Id:
2629
Gene Symbol:
GBA
GBA
0.110
GeneticVariation
phenotype
BEFREE
Resting tremor was observed in a lower frequency in GBA mutation carries.
28991672
2017
×
Entrez Id:
120892
Gene Symbol:
LRRK2
LRRK2
0.110
GeneticVariation
phenotype
BEFREE
The clinical characteristics of affected family members were similar to those described in PD families with other mutations in LRRK2 codon 1441 and included resting tremor , rigidity, bradykinesia, unilateral onset, and a good response to levodopa.Age at onset ranged from 41 to 76.
27111571
2016
×
Entrez Id:
4137
Gene Symbol:
MAPT
MAPT
0.110
GeneticVariation
phenotype
BEFREE
New features included hemispatial neglect and unilateral resting tremor not previously reported for P301L MAPT mutation.
20561037
2011
×
Entrez Id:
2629
Gene Symbol:
GBA
GBA
0.110
Biomarker
phenotype
HPO
×
Entrez Id:
120892
Gene Symbol:
LRRK2
LRRK2
0.110
Biomarker
phenotype
HPO